Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge

Published:2020-08-12 Issue:9 Volume:16 Page:2042-2050
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Jang Hyesun¹²,Meyers Lauren M.³,Boyle Christine³,De Groot Anne S.²³,Moise Lenny³⁴,Ross Ted M.¹²

Affiliation:

1. Department of Infectious Diseases, University of Georgia, Athens, GA, USA

2. Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA

3. EpiVax, Providence, RI, USA

4. Institute of Immunology and Informatics, Department of Cell and Molecular Biology, University of Rhode Island, Providence, RI, USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1793711

Reference31 articles.

1. Pandemic Preparedness and Response — Lessons from the H1N1 Influenza of 2009

2. Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response

3. Low immunogenicity predicted for emerging avian-origin H7N9

4. Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses;mSphere;2024-07-30

2. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses;2024-02-29

3. Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses;Pharmaceutics;2024-01-13

4. Neoadjuvant personalized cancer vaccines: the final frontier?;Expert Review of Vaccines;2024-01-10

5. A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses;Frontiers in Immunology;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3